{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:03:30Z","timestamp":1794445410207,"version":"4.9.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This study was supported by Nantong Municipal Health Commission General Project","award":["MS2023031"],"award-info":[{"award-number":["MS2023031"]}],"id":[{"id":"https:\/\/ror.org\/0578pqz98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Fat attenuation index (FAI) is currently used in research on coronary atherosclerotic heart disease, but there are no reports on FAI applications in coronary artery spasm (CAS). In this study, we explored the association between pericoronary FAI and CAS. Patients who had chest pain and stenosis\u2005&lt;\u200550% in major coronary branches, as indicated by coronary CT angiography (CCTA) at our hospital from January 2022 to June 2023 were included. According to the diagnostic criteria for vasospastic angina published by the Japanese Circulation Society in 2013, patients confirmed to have CAS were assigned to a CAS group, while those who were not consistent with CAS and had a negative treadmill test were assigned to a control group. Pericoronary FAI and circulating inflammatory factor levels were measured at enrollment. Count data were analyzed using the \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      test, measurement data using the\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test or nonparametric test, and CAS-related risk factors using multivariate logistic regression. There were 230 patients in the CAS group and 112 patients in the control group. The pericoronary FAI and smoking rate were significantly lower in the control group than in the CAS group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05), but there were no significant differences in other data, including general clinical data, medication use, and circulating inflammatory factor levels (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). Univariate analysis exhibited that the CAS-related risk factors included smoking, diabetes, high-density lipoprotein cholesterol, and pericoronary FAI. Multivariate logistic regression indicated that smoking and FAI around the left anterior descending branch were significantly associated with CAS. Elevated pericoronary FAI is an independent risk factor for CAS. Local coronary inflammation plays a dominant role in CAS, while circulating inflammatory factor levels seem not to be associated with CAS.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050746","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:51Z","timestamp":1789750911000},"page":"e50746","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between pericoronary CT fat attenuation index and coronary artery spasm"],"prefix":"10.1097","volume":"105","author":[{"given":"Chen","family":"Yu","sequence":"first","affiliation":[{"name":"The Department of Cardiology, Affiliated Maternity and Child Health Care Hospital of Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Qiang","family":"Sheng","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, Nantong First People\u2019s Hospital, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Medical Imaging, Nantong First People\u2019s Hospital, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ming","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, Ruici Hospital of Nantong City, Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, Nantong First People\u2019s Hospital, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Fei","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, Nantong First People\u2019s Hospital, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Xue","family":"Chen","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, Nantong First People\u2019s Hospital, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/jcdd12020064","article-title":"ANOCA, INOCA, MINOCA: the new frontier of coronary syndromes.","volume":"12","author":"Parlati","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes.","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"R3-20260922","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina.","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"key":"R4-20260922","first-page":"e003153","article-title":"Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association.","volume":"9","author":"Takagi","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R5-20260922","first-page":"327","article-title":"Coronary artery spasm: new insights from the Japanese coronary spasm association.","volume":"13","author":"Teragawa","year":"2021","journal-title":"World J Cardiol"},{"key":"R6-20260922","first-page":"1487","article-title":"Vasospastic acute myocardial infarction: prognosis and management in the contemporary era.","volume":"42","author":"Sternheim","year":"2021","journal-title":"Eur Heart J"},{"key":"R7-20260922","first-page":"343","article-title":"Noninvasive treatment of acute myocardial infarction: clinical profile and predictors of poor prognosis.","volume":"68","author":"Ferreiro","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/PSY.0000000000000682","article-title":"Coronary artery spasm, coronary reactivity, and their psychological context.","volume":"81","author":"Mehta","year":"2019","journal-title":"Psychosom Med"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2169\/internalmedicine.53.2705","article-title":"Differences and interactions between risk factors for coronary spasm and atherosclerosis-smoking, aging, inflammation, and blood pressure.","volume":"53","author":"Morita","year":"2014","journal-title":"Intern Med"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"5894586","DOI":"10.1155\/2020\/5894586","article-title":"Coronary artery spasm: new insights.","volume":"2020","author":"Matta","year":"2020","journal-title":"J Interv Cardiol"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/eurheartj\/ehu427","article-title":"2014 Williams Harvey lecture: importance of coronary vasomotion abnormalities-from bench to bedside.","volume":"35","author":"Shimokawa","year":"2014","journal-title":"Eur Heart J"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1253\/circj.CJ-15-0149","article-title":"Association of adventitial vasa vasorum and inflammation with coronary hyperconstriction after drug-eluting stent implantation in pigs in vivo.","volume":"79","author":"Nishimiya","year":"2015","journal-title":"Circ J"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"eaal2658","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat.","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data.","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"e200563","DOI":"10.1148\/ryct.2021200563","article-title":"Assessing cardiovascular risk by using the fat attenuation index in coronary CT angiography.","volume":"3","author":"Kl\u00fcner","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jamacardio.2018.1997","article-title":"Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease.","volume":"3","author":"Goeller","year":"2018","journal-title":"JAMA Cardiol"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jacc.2020.05.078","article-title":"Perivascular fat attenuation index stratifies cardiac risk associated with high-risk plaques in the CRISP-CT study.","volume":"76","author":"Oikonomou","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R18-20260922","first-page":"2772","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina).","volume":"78","author":"Shimokawa","year":"2014","journal-title":"Circ J"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.CIR.101.11.1319","article-title":"Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1\u03b2.","volume":"101","author":"Kandabashi","year":"2000","journal-title":"Circulation"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","article-title":"Rho-kinase is an important therapeutic target in cardiovascular medicine.","volume":"25","author":"Shimokawa","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI118476","article-title":"Chronic treatment with interleukin-1\u03b2 induces coronary intimal lesions and vasospastic responses in pigs in vivo: the role of platelet-derived growth factor.","volume":"97","author":"Shimokawa","year":"1996","journal-title":"J Clin Invest"},{"key":"R22-20260922","first-page":"949","article-title":"Quantitative analysis of adipose tissue distribution in the human body using PET-CT with 18F-FDG.","volume":"8","author":"Yokoyama","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","article-title":"Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group.","volume":"349","author":"Haverkate","year":"1997","journal-title":"Lancet"},{"key":"R25-20260922","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1253\/circj.CJ-22-0779","article-title":"JCS\/CVIT\/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction.","volume":"87","author":"Hokimoto","year":"2023","journal-title":"Circ J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:32Z","timestamp":1790100212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":26,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050746","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2025-12-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}